Walleye Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-213,500
| Closed | -$28.2M | – | 4838 |
|
|
2025
Q1 | $28.2M | Buy |
+213,500
| New | +$26.6M | 0.07% | 334 |
|
|
2024
Q3 | – | Sell |
-19,400
| Closed | -$1.33M | – | 4688 |
|
|
2024
Q2 | $1.33M | Sell |
19,400
-6,800
| -26% | -$472K | ﹤0.01% | 1870 |
|
|
2024
Q1 | $1.81M | Buy |
+26,200
| New | +$1.8M | ﹤0.01% | 1792 |
|
|
2023
Q4 | – | Sell |
-3,400
| Closed | -$177K | – | 5590 |
|
|
2023
Q3 | $177K | Buy |
+3,400
| New | +$198K | ﹤0.01% | 3684 |
|
|
2023
Q2 | – | Sell |
-34,500
| Closed | -$1.87M | – | 5301 |
|
|
2023
Q1 | $1.87M | Buy |
34,500
+15,700
| +84% | +$759K | ﹤0.01% | 1737 |
|
|
2022
Q4 | $995K | Sell |
18,800
-4,200
| -18% | -$210K | ﹤0.01% | 2222 |
|
|
2022
Q3 | $1.07M | Buy |
23,000
+18,200
| +379% | +$951K | ﹤0.01% | 2208 |
|
|
2022
Q2 | $274K | Sell |
4,800
-5,200
| -52% | -$295K | ﹤0.01% | 3456 |
|
|
2022
Q1 | $612K | Buy |
10,000
+6,800
| +213% | +$353K | ﹤0.01% | 2702 |
|
|
2021
Q4 | $167K | Sell |
3,200
-3,000
| -48% | -$126K | ﹤0.01% | 4046 |
|
|
2021
Q3 | $231K | Sell |
6,200
-32,100
| -84% | -$1.12M | ﹤0.01% | 3714 |
|
|
2021
Q2 | $1.56M | Buy |
38,300
+38,000
| +12,667% | +$1.4M | 0.01% | 1713 |
|
|
2021
Q1 | $10K | Buy |
300
+100
| +50% | +$3.47K | ﹤0.01% | 4635 |
|
|
2020
Q4 | $6K | Sell |
200
-7,100
| -97% | -$187K | ﹤0.01% | 4478 |
|
|
2020
Q3 | $187K | Buy |
+7,300
| New | +$167K | ﹤0.01% | 3041 |
|
|
2020
Q2 | – | Sell |
-10,700
| Closed | -$164K | – | 4688 |
|
|
2020
Q1 | $164K | Sell |
10,700
-483,800
| -98% | -$10.5M | ﹤0.01% | 2779 |
|
|
2019
Q4 | $17M | Buy |
494,500
+477,000
| +2,726% | +$5.72M | 0.12% | 156 |
|
|
2019
Q3 | $131K | Buy |
17,500
+17,300
| +8,650% | +$166K | ﹤0.01% | 3198 |
|
|
2019
Q2 | $3K | Sell |
200
-300
| -60% | -$3.85K | ﹤0.01% | 3927 |
|
|
2019
Q1 | $6K | Sell |
500
-5,000
| -91% | -$63.9K | ﹤0.01% | 4034 |
|
|
2018
Q4 | $63K | Buy |
+5,500
| New | +$88.8K | ﹤0.01% | 4063 |
|
Other funds holding ITCI
Walleye Trading's ITCI Position: Q2 2025 in Review
Walleye Trading sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 8,000 shares — an estimated $1.06M sold.
Walleye Trading first reported a position in ITCI in Q2 2017 and held it in 18 quarters. The position peaked at $1.74M in Q4 2019. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Walleye Trading reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Walleye Trading sold 8,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.06M.
- Walleye Trading first reported a position in Intra-Cellular Therapies Inc. in Q2 2017 and held it in 18 quarters.
- Walleye Trading's Intra-Cellular Therapies Inc. position peaked at $1.74M in Q4 2019.
- 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.